How Women in Malawi Choose and Use Injectable or Oral HIV Prevention Medicine
Studies which HIV prevention option women choose, injectable or pills, and how they use it.
Plain-language title generated from the registry record
Registry title: BetterInfo on Women's PrEP Choices and Outcomes in Malawi
Key facts
- Where
- Blantyre, MalawiSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women in Blantyre, Malawi who started PrEP (injectable or oral) at 20 supported sites and then stopped coming for visits. Health care providers and partners can join interviews.
- Age
- 18 years or older
- Sex
- Women (men are left out of the client interviews only)
- Disease stage
- Women at risk of HIV who started PrEP and missed their PrEP visit by 3 months or more, with unknown outcomes.
- Earlier treatment
- Must have started injectable or oral PrEP at a supported facility and been lost to follow up within the 2 years before sampling.
Main reasons for not taking part
- Documented in the records as having stopped PrEP after talking with a provider
- Known to have died
- Records show a transfer out of the supported facilities
- Refused follow-up by phone or in person
- Does not speak Chichewa or English
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 110 years old?
Source: NCT07579754, who can take part
Where in Malawi
- Johns Hopkins Research Project MalawiBlantyre, MalawiTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Johns Hopkins Bloomberg School of Public Health
- Trial code
- NCT07579754
- Record updated
- 15 July 2026
- Original description
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.Read full original descriptionShow less
BetterInfo Tracing Approach to Evaluate HIV PrEP Choices and Use Over Time Among Women in Blantyre, Malawi
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
Inclusion: The population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre sites supported through PathToScale. PathToScale supports various types of facilities including public health clinics, drop-in centers for prioritized populations (DICs), and private hospitals/clinics; Those eligible for sampling are as follows:; Adult women ≥18 years; and; Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and; Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and; Has a registered phone number for contact; Those eligible for tracing are as follows:; Women sampled per eligibility criteria above; and; Women who have indicated permission for in-person follow-up; Health Care Providers, Implementing Partners, Ministry of Health (MOH) Stakeholers; providers and implementing partners from PathtoScale, and Ministry of Health stakeholders will be consented to participate in in-depth-interviews.
Exclusion: Those excluded from sampling or tracing include:; Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or; Women who are known to have died; or; Women who have EMR documented transfers out of PathToScale supported facilities; or; Women refusing follow-up via phone on their ScanForm; or; Women refusing follow-up in person (during phone tracing); or; Women who do not speak Chichewa or English; or; Men (excluded from client interviews only).